Valuation: Progyny, Inc.

Market Cap 2.07B 1.8B 1.7B 1.55B 2.9B 199B 2.91B 20.37B 7.87B 101B 7.78B 7.61B 325B P/E 2026 *
21.1x
P/E 2027 * 17.9x
Enterprise Value 1.9B 1.66B 1.57B 1.42B 2.66B 183B 2.68B 18.72B 7.23B 92.88B 7.15B 7B 299B EV / Sales 2026 *
1.39x
EV / Sales 2027 * 1.13x
Free-Float
75.41%
Yield 2026 *
-
Yield 2027 * -
1 day+0.44%
1 week+0.18%
Current month+6.02%
1 month+7.11%
3 months+3.12%
6 months+50.30%
Current year+5.65%
1 week 26.95
Extreme 26.95
27.98
1 month 25.24
Extreme 25.24
27.98
Current year 16.1
Extreme 16.1
33.06
1 year 16.1
Extreme 16.1
33.06
3 years 13.39
Extreme 13.39
42.08
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 31/12/2021
Director of Finance/CFO 60 14/09/2020
Chief Operating Officer 56 16/04/2025
Director TitleAgeSince
Chairman 66 31/12/2021
Director/Board Member 77 15/12/2016
Director/Board Member 58 31/12/2021
Date Insider Type Main position Quantity % Market Cap. Importance
10/09/26 Exercice

Director

66,000 0.0860%
04/09/26 Tax

General Counsel

-479 0.0006%
04/09/26 Tax

Chief Financial Officer

-479 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+0.44%+0.18%+25.43%-20.70% 2.07B
+0.45%-2.93%+10.33%-22.56% 337B
-0.80%-1.34%+33.22%-7.01% 89.84B
-0.26%-2.00%-7.19%-2.80% 72.93B
+0.44%-3.62%+43.37%-17.96% 46.17B
-2.97%-0.44%+103.34%-3.98% 33.15B
-2.10%+0.25%+13.88%-38.71% 10.68B
-1.76%-5.31%+45.28%+294.69% 2.41B
-4.02%-34.56%-49.94%+37.34% 1.8B
Average -1.22%-4.62%+24.19%+24.26% 66.21B
Weighted average by Cap. -0.32%-3.10%+19.45%-15.22%

Financials

2026 *2027 *
Net sales 1.37B 1.2B 1.13B 1.03B 1.92B 132B 1.93B 13.51B 5.22B 67.02B 5.16B 5.05B 216B 1.51B 1.32B 1.24B 1.13B 2.11B 145B 2.12B 14.86B 5.74B 73.74B 5.68B 5.55B 237B
Net income 106M 92.52M 87.34M 79.35M 149M 10.19B 149M 1.04B 403M 5.18B 399M 390M 16.67B 125M 109M 103M 93.59M 175M 12.02B 176M 1.23B 476M 6.11B 471M 460M 19.66B
Net Debt -168M -146M -138M -125M -234M -16.07B -236M -1.65B -636M -8.17B -630M -616M -26.3B -358M -312M -294M -267M -500M -34.31B -503M -3.52B -1.36B -17.45B -1.34B -1.31B -56.14B
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
18/09/26 US$27.13 +0.44% 2,925,099
17/09/26 US$27.01 -1.35% 828,708
16/09/26 US$27.38 -1.37% 864,466
15/09/26 US$27.76 -0.32% 690,797
14/09/26 US$27.85 +1.83% 1,064,567
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
27.13USD
Average target price
34.42USD
Spread / Average Target
+26.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGNY Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!